Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

SEMA3A Inhibitors

Common SEMA3A Inhibitors include, but are not limited to Sunitinib, Free Base CAS 557795-19-4, 2-Methoxyestradiol CAS 362-07-2, VEGFR2 Kinase Inhibitor I CAS 15966-93-5, AZD1480 CAS 935666-88-9 and BIBF1120 CAS 656247-17-5.

SEMA3A inhibitors belong to a chemical class designed to interact with and modulate the activity of SEMA3A, which is a secreted protein belonging to the semaphorin family. SEMA3A plays a critical role in various biological processes, particularly in axon guidance and neural development. It functions as a repulsive guidance cue, helping to guide developing axons by regulating their growth and pathfinding. By binding to its receptors on the surface of growth cones, SEMA3A provides crucial cues that steer axons away from inappropriate areas, ensuring accurate neural circuit formation.

Inhibiting SEMA3A involves disrupting its interactions with its receptors, thereby affecting the guidance cues provided to growing axons. By exploring the effects of SEMA3A inhibitors, researchers aim to gain deeper insights into the complex molecular mechanisms that underlie neural development and axon guidance. This research contributes to our understanding of how neural circuits are formed during development and how abnormalities in these processes can lead to neurological disorders. Additionally, the study of SEMA3A inhibitors sheds light on the broader role of semaphorin family proteins in various biological contexts beyond neural development, unveiling applications in different fields of biology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Tyrosine kinase inhibitor affecting RTKs involved in SEMA3A pathways.

2-Methoxyestradiol

362-07-2sc-201371
sc-201371A
10 mg
50 mg
$71.00
$288.00
6
(1)

Endogenous metabolite that may inhibit SEMA3A-induced angiogenesis by affecting downstream pathways.

VEGFR2 Kinase Inhibitor I

15966-93-5sc-202850
1 mg
$150.00
1
(0)

Inhibits FGFR tyrosine kinases, which might intersect with SEMA3A signaling.

AZD1480

935666-88-9sc-364735
sc-364735A
5 mg
50 mg
$124.00
$1072.00
11
(2)

JAK2 inhibitor that may modulate SEMA3A signaling through downstream effects on related pathways.

Ulixertinib

869886-67-9sc-507296
10 mg
$176.00
(0)

Reversible inhibitor of ERK1/2, downstream of SEMA3A pathways, potentially affecting SEMA3A effects.

BIBF1120

656247-17-5sc-364433
sc-364433A
5 mg
10 mg
$184.00
$321.00
2
(0)

Multitarget tyrosine kinase inhibitor affecting RTKs, indirectly influencing SEMA3A-related processes.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Multikinase inhibitor targeting various RTKs, potentially affecting SEMA3A signaling.

Dovitinib, Free Base

405169-16-6sc-396771
sc-396771A
10 mg
25 mg
$170.00
$350.00
(0)

Pan-RTK inhibitor impacting SEMA3A-related processes through its effects on RTKs.

Pazopanib Hydrochloride

635702-64-6sc-364564
sc-364564A
10 mg
25 mg
$107.00
$230.00
1
(1)

Multitarget tyrosine kinase inhibitor potentially influencing SEMA3A pathways via RTK inhibition.

Tivozanib

475108-18-0sc-475339
5 mg
$320.00
(0)

Tyrosine kinase inhibitor potentially affecting SEMA3A signaling through inhibitory effects on RTKs.